Exploring awareness, attitudes, and perceived role among oral health providers regarding HPV-related oral cancers

Journal of Public Health Dentistry

Volumn 71, Issue 2, 2011, Pages 136-142

  Daley, Ellen ^a   Debate, Rita ^a   Dodd, Virginia ^b   Dyer, Karen ^c   Fuhrmann, Hollie ^a,c   Helmy, Hannah ^c   Smith, Sarah A ^c  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b UNIVERSITY OF FLORIDA   (United States)

^c UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

HPV; oral cancer; oral health providers

Indexed keywords

WART VIRUS VACCINE;

ADULT; AGED; ARTICLE; CONFIDENTIALITY; DENTAL ASSISTANT; DENTAL EDUCATION; DENTAL HEALTH EDUCATION; DENTIST; DOCTOR PATIENT RELATION; EDUCATION; FEMALE; HEALTH PERSONNEL ATTITUDE; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN RELATION; INFORMATION PROCESSING; MALE; MASS SCREENING; MIDDLE AGED; MOUTH TUMOR; PAPILLOMAVIRUS INFECTION; PATIENT EDUCATION; PHYSIOLOGY; PROFESSIONAL STANDARD; PSYCHOLOGICAL ASPECT; RISK ASSESSMENT; VIROLOGY;

ADULT; AGED; ATTITUDE OF HEALTH PERSONNEL; CONFIDENTIALITY; DENTAL HYGIENISTS; DENTIST-PATIENT RELATIONS; DENTISTS; EDUCATION, DENTAL; FEMALE; FOCUS GROUPS; HEALTH EDUCATION, DENTAL; HUMAN PAPILLOMAVIRUS 16; HUMAN PAPILLOMAVIRUS 18; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; MOUTH NEOPLASMS; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; PATIENT EDUCATION AS TOPIC; PROFESSIONAL ROLE; PROFESSIONAL-PATIENT RELATIONS; RISK ASSESSMENT; YOUNG ADULT;

EID: 79958069659     PISSN: 00224006     EISSN: 17527325     Source Type: Journal    
DOI: 10.1111/j.1752-7325.2011.00212.x     Document Type: Article

References (13)

1. Centers for Disease Control and Prevention (CDC) [Internet]. Atlanta: CDC; [updated 2010 Feb 10[; [cited 2010 Feb 19]. Human papillomavirus (HPV); [about 2 screens]. Available from
2. Cogliano V, Baan R, Straif K, Grosse Y, Secretan B, El Ghissassi F,. Carcinogenicity of human papillomaviruses. Lancet Oncol. 2005; 6: 204. (Pubitemid 40450709)
3. American Cancer Society (ACS) [Internet]. Atlanta: ACS; c2010 [updated 2009 Sep 24]; [cited 2010 Feb 19]. What are the key statistics about oral cavity and oropharyngeal cancers? [1 screen]. Available from
4. Sturgis EM, Cinciripini PM,. Trends in head and neck cancer incidence in relation to smoking prevalence: an emerging epidemic of human papillomavirus-associated cancers ? Cancer. 2007; 110: 1429-35. (Pubitemid 47463055)
5. Chaturvedi AK, Engels EA, Anderson WF, Gillison ML,. Incidence trends for human papillomavirus-related and -unrelated oral squamous cell carcinomas in the United States. J Clin Oncol. 2008; 26: 612-9. (Pubitemid 351264356)
6. Gillison ML, Chaturvedi AK, Lowy DR,. HPV prophylactic vaccines and the potential prevention of noncervical cancers in both men and women. Cancer. 2008; 113 Suppl 10: 3036-46.
7. Gillison ML, D'Souza G, Westra W, Sugar E, Xiao W, Begum S, Viscidi R., Distinct risk factor profiles for human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck cancers. J Natl Cancer Inst. 2008; 100: 407-20. (Pubitemid 351480511)
8. Termine N, Panzarella V, Falaschini S, Russo A, Matranga D, Lo Muzio L, Campisi G., HPV in oral squamous cell carcinoma versus head and neck squamous cell carcinoma biopsies: a meta-analysis (1988-2007). Ann Oncol. 2008; 19: 1681-90.
9. Gillison ML,. Human papillomavirus-related diseases: oropharynx cancers and potential implications for adolescent HPV vaccination. J Adolesc Health. 2008; 43 Suppl 4: S52-60.
10. Hennessey PT, Westra WH, Califano JA,. Human papillomavirus and head and neck squamous cell carcinoma: recent evidence and clinical implications. J Dent Res. 2009; 88: 300-6.
11. Campisi G, Giovannelli L,. Controversies surrounding human papilloma virus infection, head & neck versus oral cancer, implications for prophylaxis and treatment. Head Neck Oncol. 2009; 1 (1): 8.
12. Joura EA, Leodolter S, Hernandez-Avila M, Wheeler CM, Perez G, Koustsky LA, Garland SM, Harper DM, Tang GW, Ferris DG, Steben M, Jones RW, Bryan J, Taddeo FJ, Bautista OM, Esser MT, Sings HL, Nelson M, Boslego JW, Sattler C, Barr E, Paavonen J., Efficacy of a quadrivalent prophylactic human papillomavirus (types 6, 11, 16, and 18) L1 virus-like-particle vaccine against high-grade vulval and vaginal lesions: a combined analysis of three randomised clinical trials. Lancet. 2007; 369 (9574): 1693-702. (Pubitemid 46783792)
13. Centers for Disease Control and Prevention (CDC). Behavioral risk factor surveillance system survey data. Atlanta (GA): U.S. Department of Health and Human Services, Centers for Disease Control and Prevention; 2006.